Magnolia Private Wealth’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-22,219
Closed -$310K 156
2026
Q1
$310K Sell
22,219
-2,875
-11% -$40.3K 0.21% 97
2025
Q4
$361K Sell
25,094
-38,675
-61% -$582K 0.25% 79
2025
Q3
$1.02M Sell
63,769
-4,420
-6% -$72.8K 0.74% 37
2025
Q2
$1.21M Buy
68,189
+49,560
+266% +$965K 0.94% 27
2025
Q1
$388K Buy
18,629
+700
+4% +$13.3K 0.32% 68
2024
Q4
$331K Buy
+17,929
New +$345K 0.28% 77

Other funds holding BTAL

Magnolia Private Wealth's BTAL Position: Q2 2026 in Review

Magnolia Private Wealth sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026, closing a stake of 22,219 shares — an estimated $310K sold.

Magnolia Private Wealth first reported a position in BTAL in Q4 2024 and held it in 6 quarters. The position peaked at $1.21M in Q2 2025. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Magnolia Private Wealth reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2026 after selling out during the quarter.
  • Magnolia Private Wealth sold 22,219 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $310K.
  • Magnolia Private Wealth first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2024 and held it in 6 quarters.
  • Magnolia Private Wealth's AGF US Market Neutral Anti-Beta Fund position peaked at $1.21M in Q2 2025.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Magnolia Private Wealth's 13F filing for Q2 2026, filed 5 Aug 2026.